Pharmaceutical Isolator Market is expected to reach US$ 10,560.30 million by 2028

The pharmaceutical isolator market size is expected to reach US$ 10,560.30 million by 2028, registering at a CAGR of 8.5% from 2021 to 2028.

Floor Standing Configuration Segment to Grow at Highest CAGR During 2021–2028

The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.    

Pharmaceutical Isolator Market, by Region, 2021 (%)

---

Pharmaceutical Isolator Market Size, Revenue Analysis 2028

Download Free Sample

---

Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Configuration (Floor Standing, Modular, Mobile, Compact, Tabletop, and Portable), Application (Aseptic Isolators, Containment Isolators, Sampling and Weighing Isolators, Fluid Dispensing Isolators, and Others), and End User (Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Laboratories, and Others); and Geography

• Based on type, the pharmaceutical isolator market is segmented into open isolator and closed isolator. The open isolator segment held a larger share of the market in 2021, and the same segment is anticipated to register a higher CAGR in the market during the forecast period.
• Based on pressure, the pharmaceutical isolator market is segmented into positive pressure and negative pressure. In 2021, the positive pressure segment held a larger share of the market; however, the negative pressure segment is expected to grow at the fastest rate during the forecast period.
• Based on configuration, the pharmaceutical isolator market is segmented into floor standing, modular, mobile, compact, tabletop, and portable. The floor standing segment is likely to hold the largest share of the market, and the same segment is anticipated to register the highest CAGR in the market during the forecast period. Growth of the floor standing segment is attributed to improved efficiency, coupled with more quick operations.
• Based on application, the pharmaceutical isolator market is segmented into aseptic isolators, containment isolators, sampling and weighing isolators, fluid dispensing isolators, and others. The aseptic isolator segment is likely to hold the largest share of the market. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.   
• Based on end user, the pharmaceutical isolator market is segmented into hospitals, pharmaceutical and biotechnology companies, research and academic laboratories, and others. The pharmaceutical and biotechnology companies’ segment is likely to hold the largest share of the market, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

The COVID-19 pandemic has become the most significant challenge across the world. It has disturbed various trades and businesses across the world. However, the pandemic has brought several growth opportunities to the pharmaceutical and biopharmaceutical companies to strengthen their research and development for innovating vaccines against the novel coronavirus. The companies are performing clinical trials to curb the spread of the COVID-19 virus. Thus, increased clinical trials will lead to vital opportunities for the pharmaceutical isolator providers for biopharmaceutical companies.  

ITECO S.R.L.; Schematic Engineering Industries; Nuaire Inc.; Comecer; Getinge AB; Hosokawa Micron Group; Fedegari Autoclavi S.p.A.; Azbil Telstar; Gelman Singapore; and Bioquell (Ecolab Solution) are among the leading companies operating in the pharmaceutical isolator market.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com